These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 240523)

  • 1. A rapid method for the determination of deoxycytidylate deaminase activity in pregnancy serum.
    Targett-Adams L; Jones DD; Williams GF
    Clin Chim Acta; 1975 Sep; 63(3):377-82. PubMed ID: 240523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum deoxycytidylate deaminase as an index of high-risk pregnancy.
    Williams GF; Jones DD
    Br J Obstet Gynaecol; 1982 Apr; 89(4):309-13. PubMed ID: 7073998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum deoxycytidylate deaminase activity after myocardial infarction.
    Roberts RG; Davies AG; Jones DD
    Ann Clin Biochem; 1978 Nov; 15(6):316-9. PubMed ID: 736490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma urate and serum deoxycytidylate deaminase measurements for the early diagnosis of pre-eclampsia.
    Redman CW; Williams GF; Jones DD; Wilkinson RH
    Br J Obstet Gynaecol; 1977 Dec; 84(12):904-8. PubMed ID: 588501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of serum cytidine deaminase during pregnancy.
    Jones DD; Bahijri S; Roberts EL; Williams GF
    Br J Obstet Gynaecol; 1982 Apr; 89(4):314-7. PubMed ID: 7073999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deoxycytidylate deaminase in the diagnosis of acute myocardial infarction.
    Georgiades C; Cokkinos DV; Kalofoutis A; Miras C
    Acta Cardiol; 1985; 40(2):247-54. PubMed ID: 3873159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deoxycytidylate deaminase activity and its template stability in human acute lymphoblastic and myeloblastic leukaemic cells.
    Bernengo MG; Pegoraro L
    Eur J Cancer (1965); 1976 Aug; 12(8):611-6. PubMed ID: 1067968
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetic interaction of 5-AZA-2'-deoxycytidine-5'-monophosphate and its 5'-triphosphate with deoxycytidylate deaminase.
    Momparler RL; Rossi M; Bouchard J; Vaccaro C; Momparler LF; Bartolucci S
    Mol Pharmacol; 1984 May; 25(3):436-40. PubMed ID: 6203026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deoxycytidylate deaminase. Purification and some properties of the enzyme isolated from human spleen.
    Ellims PH; Kao AY; Chabner BA
    J Biol Chem; 1981 Jun; 256(12):6335-40. PubMed ID: 7240207
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting deoxycytidylate deaminase activity in some transplantable rat hepatomas.
    Blocker R; Roth JS
    Cancer Res; 1977 Jun; 37(6):1918-22. PubMed ID: 192466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of 5-fluorodeoxycytidine and tetrahydrouridine to exploit high levels of deoxycytidylate deaminase in tumors to achieve DNA- and target-directed therapies.
    Mekras JA; Boothman DA; Perez LM; Greer S
    Cancer Res; 1984 Jun; 44(6):2551-60. PubMed ID: 6539164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a Saccharomyces cerevisiae mutant strain deficient in deoxycytidylate deaminase activity and partial characterization of the enzyme.
    McIntosh EM; Haynes RH
    J Bacteriol; 1984 May; 158(2):644-9. PubMed ID: 6373725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of deoxynucleotide metabolism by the deoxycytidylate deaminase inhibitor 3,4,5,6-tetrahydrodeoxyuridine.
    Heinemann V; Plunkett W
    Biochem Pharmacol; 1989 Nov; 38(22):4115-21. PubMed ID: 2688654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic behaviour and allosteric regulation of human deoxycytidylate deaminase derived from leukemic cells.
    Ellims PH; Kao AY; Chabner BA
    Mol Cell Biochem; 1983; 57(2):185-90. PubMed ID: 6581381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deoxycytidylate deaminase from T2-infected Escherichia coli.
    Maley GF
    Methods Enzymol; 1978; 51():412-8. PubMed ID: 357901
    [No Abstract]   [Full Text] [Related]  

  • 16. Allosteric transitions associated with the binding of substrate and effector ligands to T2 phage induced deoxycytidylate deaminase.
    Maley GF; Maley F
    Biochemistry; 1982 Aug; 21(16):3780-5. PubMed ID: 7138806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of an affinity-column-purified human deoxycytidylate deaminase.
    Maley GF; Lobo AP; Maley F
    Biochim Biophys Acta; 1993 Mar; 1162(1-2):161-70. PubMed ID: 8448179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on identifying the allosteric binding sites of deoxycytidylate deaminase.
    Maley F; Maley GF
    J Biol Chem; 1982 Oct; 257(20):11876-8. PubMed ID: 6749849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive, optimized assay for serum AMP deaminase.
    Pedersen RC; Berry AJ
    Clin Chem; 1977 Sep; 23(9):1726-33. PubMed ID: 19169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxycytidine monophosphate deaminase in Acetabularia: properties and regulation in the early generative phase.
    Bannwarth H; Ikehara N; Schweiger HG
    Eur J Cell Biol; 1982 Jun; 27(2):200-5. PubMed ID: 7117267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.